Time to get personal: A framework for personalized targeting of oxidative stress in neurotoxicity and neurodegenerative disease

Gooch, 2017, The burden of neurological disease in the United States: a summary report and call to action, Ann Neurol, 81, 479, 10.1002/ana.24897 Massaad, 2011, Reactive oxygen species in the regulation of synaptic plasticity and memory, Antioxid Redox Signal, 14, 2013, 10.1089/ars.2010.3208 Niedzielska, 2016, Oxidative stress in neurodegenerative diseases, Mol Neurobiol, 53, 4094, 10.1007/s12035-015-9337-5 Cui, 2012, Oxidative stress, mitochondrial dysfunction, and aging, J Signal Transduct, 2012, 646354 Kim, 2015, The role of oxidative stress in neurodegenerative diseases, Exp Neurobiol, 24, 325, 10.5607/en.2015.24.4.325 Harris, 2012, Synaptic energy use and supply, Neuron, 75, 762, 10.1016/j.neuron.2012.08.019 Payne, 2015, Mitochondrial dysfunction in aging: much progress but many unresolved questions, Biochim Biophys Acta, 1847, 1347, 10.1016/j.bbabio.2015.05.022 Perry, 2012, Innate inflammation in Parkinson's disease, Cold Spring Harb Perspect Med, 2, a009373, 10.1101/cshperspect.a009373 Kraft, 2011, Features of microglia and neuroinflammation relevant to environmental exposure and neurotoxicity, Int J Environ Res Public Health, 8, 2980, 10.3390/ijerph8072980 Liddelow, 2017, Neurotoxic reactive astrocytes are induced by activated microglia, Nature, 541, 481, 10.1038/nature21029 Rojo, 2014, Redox control of microglial function: molecular mechanisms and functional significance, Antioxid Redox Signal, 21, 1766, 10.1089/ars.2013.5745 Abramov, 2003, Changes in intracellular calcium and glutathione in astrocytes as the primary mechanism of amyloid neurotoxicity, J Neurosci, 23, 5088, 10.1523/JNEUROSCI.23-12-05088.2003 Hernandes, 2012, NADPH oxidase and neurodegeneration, Curr Neuropharmacol, 10, 321, 10.2174/157015912804499483 Surace, 2012, Targeting microglia-mediated neurotoxicity: the potential of NOX2 inhibitors, Cell Mol Life Sci, 69, 2409, 10.1007/s00018-012-1015-4 Waak, 2009, Regulation of astrocyte inflammatory responses by the Parkinson's disease-associated gene DJ-1, FASEB J, 23, 2478, 10.1096/fj.08-125153 Ishihara, 2015, Dual role of superoxide dismutase 2 induced in activated microglia: oxidative stress tolerance and convergence of inflammatory responses, J Biol Chem, 290, 22805, 10.1074/jbc.M115.659151 Choi, 2006, Oxidative damage of DJ-1 is linked to sporadic Parkinson and Alzheimer diseases, J Biol Chem, 281, 10816, 10.1074/jbc.M509079200 Raninga, 2017, The multifaceted roles of DJ-1 as an antioxidant, Adv Exp Med Biol, 1037, 67, 10.1007/978-981-10-6583-5_6 Minlikeeva, 2016, Single-nucleotide polymorphisms and markers of oxidative stress in healthy women, PLoS One, 11, e0156450, 10.1371/journal.pone.0156450 Bastaki, 2006, Genotype-activity relationship for Mn-superoxide dismutase, glutathione peroxidase 1 and catalase in humans, Pharmacogenet Genomics, 16, 279, 10.1097/01.fpc.0000199498.08725.9c Aoyama, 2013, Impaired glutathione synthesis in neurodegeneration, Int J Mol Sci, 14, 21021, 10.3390/ijms141021021 Ballatori, 2009, Glutathione dysregulation and the etiology and progression of human diseases, Biol Chem, 390, 191, 10.1515/BC.2009.033 Hayes, 2000, Glutathione S-transferase polymorphisms and their biological consequences, Pharmacology, 61, 154, 10.1159/000028396 Kumar, 2017, Role of Glutathione-S-transferases in neurological problems, Expert Opin Ther Pat, 27, 299, 10.1080/13543776.2017.1254192 Lo, 2007, Genetic polymorphism and function of glutathione S-transferases in tumor drug resistance, Curr Opin Pharmacol, 7, 367, 10.1016/j.coph.2007.06.009 Kume, 2017, Therapeutic potential of the activators of the nuclear factor erythroid 2-related factor 2-antioxidant response element pathway in brain disorders, Biol Pharm Bull, 40, 553, 10.1248/bpb.b17-00091 Cho, 2015, Functional polymorphisms in Nrf2: implications for human disease, Free Radic Biol Med, 88, 362, 10.1016/j.freeradbiomed.2015.06.012 Pickrell, 2015, The roles of PINK1, parkin, and mitochondrial fidelity in Parkinson's disease, Neuron, 85, 257, 10.1016/j.neuron.2014.12.007 Bonda, 2011, The mitochondrial dynamics of Alzheimer's disease and Parkinson's disease offer important opportunities for therapeutic intervention, Curr Pharm Des, 17, 3374, 10.2174/138161211798072562 Chin-Chan, 2015, Environmental pollutants as risk factors for neurodegenerative disorders: Alzheimer and Parkinson diseases, Front Cell Neurosci, 9, 124, 10.3389/fncel.2015.00124 Baltazar, 2014, Pesticides exposure as etiological factors of Parkinson's disease and other neurodegenerative diseases–a mechanistic approach, Toxicol Lett, 230, 85, 10.1016/j.toxlet.2014.01.039 Wang, 2017, Paraquat and MPTP induce neurodegeneration and alteration in the expression profile of microRNAs: the role of transcription factor Nrf2, NPJ Parkinsons Dis, 3, 31, 10.1038/s41531-017-0033-1 Ortiz, 2016, Effects of antioxidant N-acetylcysteine against paraquat-induced oxidative stress in vital tissues of mice, Int J Sci Basic Appl Res, 26, 26 Lee, 2015, Antioxidant and anticoagulant status were improved by personalized dietary intervention based on biochemical and clinical parameters in cancer patients, Nutr Cancer, 67, 1083, 10.1080/01635581.2015.1073754 Gao, 2003, Critical role for microglial NADPH oxidase in rotenone-induced degeneration of dopaminergic neurons, J Neurosci, 23, 6181, 10.1523/JNEUROSCI.23-15-06181.2003 Abdelsalam, 2015, Neuroprotective effects of vildagliptin in rat rotenone Parkinson's disease model: role of RAGE-NFκB and Nrf2-antioxidant signaling pathways, J Neurochem, 133, 700, 10.1111/jnc.13087 Farina, 2013, Metals, oxidative stress and neurodegeneration: a focus on iron, manganese and mercury, Neurochem Int, 62, 575, 10.1016/j.neuint.2012.12.006 Fagundes, 2015, Direct contact with particulate matter increases oxidative stress in different brain structures, Inhal Toxicol, 27, 462, 10.3109/08958378.2015.1060278 Adedara, 2017, Quercetin improves neurobehavioral performance through restoration of brain antioxidant status and acetylcholinesterase activity in manganese-treated rats, Neurochem Res, 42, 1219, 10.1007/s11064-016-2162-z Zhang, 2004, In vitro effect of manganese chloride exposure on reactive oxygen species generation and respiratory chain complexes activities of mitochondria isolated from rat brain, Toxicol In Vitro, 18, 71, 10.1016/j.tiv.2003.09.002 Wei, 2017, Role of oxidative stress and DNA hydroxymethylation in the neurotoxicity of fine particulate matter, Toxicology, 380, 94, 10.1016/j.tox.2017.01.017 Sriram, 1997, Evidence for generation of oxidative stress in brain by MPTP: in vitro and in vivo studies in mice, Brain Res, 749, 44, 10.1016/S0006-8993(96)01271-1 Lock, 2013, Solvents and Parkinson disease: a systematic review of toxicological and epidemiological evidence, Toxicol Appl Pharmacol, 266, 345, 10.1016/j.taap.2012.11.016 Consales, 2012, Electromagnetic fields, oxidative stress, and neurodegeneration, Int J Cell Biol, 2012, 683897, 10.1155/2012/683897 Kim, 2015, Oxidative stress induced by cigarette smoke extracts in human brain cells (T98G) and human brain microvascular endothelial cells (HBMEC) in mono- and co-culture, J Toxicol Environ Health A, 78, 1019, 10.1080/15287394.2015.1043607 Block, 2007, Microglia-mediated neurotoxicity: uncovering the molecular mechanisms, Nat Rev Neurosci, 8, 57, 10.1038/nrn2038 Umeno, 2017, In vivo ROS production and use of oxidative stress-derived biomarkers to detect the onset of diseases such as Alzheimer's disease, Parkinson's disease, and diabetes, Free Radic Res, 51, 413, 10.1080/10715762.2017.1315114 Osburn, 2008, Nrf2 signaling: an adaptive response pathway for protection against environmental toxic insults, Mutat Res, 659, 31, 10.1016/j.mrrev.2007.11.006 Cervantes, 2017, Vitamin E and Alzheimer's disease-is it time for personalized medicine?, Antioxidants (Basel), 6 Jin, 2014, Mitochondria-targeted antioxidants for treatment of Parkinson's disease: preclinical and clinical outcomes, Biochim Biophys Acta, 1842, 1282, 10.1016/j.bbadis.2013.09.007